Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab plus Low-Dose Radiotherapy in Relapsed NHL
NCT00147953Phase 2Completed
- Sponsor
- University of Cologne
- Start
- Jun 2004
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in non-Hodgkin lymphoma (NHL), sponsored by University of Cologne. Started Jun 2004; status: completed.
02
Drugs
rituximab
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00147953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00147953.